2. Search Result
Search Result
Results for "

BTLA

" in MedChemExpress (MCE) Product Catalog:

4

Inhibitors & Agonists

3

Inhibitory Antibodies

11

Recombinant Proteins

1

Antibodies

1

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-P99961
    Tifcemalimab

    JS004

    		 CD28 Cancer
    Tifcemalimab (JS004) is a humanized anti-BTLA (B and T lymphocyte attenuation factor) monoclonal antibody. Tifcemalimab blocks the interaction of HVEM-BTLA by binding to BTLA, and thus blocks the inhibitory signaling pathway mediated by BTLA. Tifcemalimab can be used in research of cancer .
    Tifcemalimab
  • HY-108813
    Belatacept

    BMS 224818; LEA 29Y

    		 Others Inflammation/Immunology
    Belatacept (BMS 224818) is a selective T-cell costimulation blocker. Belatacept binds to CD 80/86 ligands and thereby inhibits the CD-28-mediated T-cell costimulation. Belatacept can be used in the research of Immunosuppression in organ transplants .
    Belatacept
  • HY-RS01669
    BTLA Human Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    BTLA Human Pre-designed siRNA Set A contains three designed siRNAs for BTLA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    BTLA Human Pre-designed siRNA Set A
    BTLA Human Pre-designed siRNA Set A
  • HY-159885
    MG-B-28

    		Others Cancer
    MG-B-28 is an inhibitor of BTLA-HVEM with an IC50 value of 906 nM. MG-B-28 promotes T-cell activation in a dose-dependent manner by blocking the BTLA-HVEM interaction .
    MG-B-28

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: